3-Bromo-6-chloroimidazo[1,2-b]pyridazine

3-Bromo-6-chloroimidazo[1,2-b]pyridazine Basic information
Product Name:3-Bromo-6-chloroimidazo[1,2-b]pyridazine
Synonyms:3-Bromo-6-chloroimidazo[1,2-b]pyridazine;IMidazo[1,2-b]pyridazine, 3-broMo-6-chloro-;3-Bromo-6-chloroimidazo[1,2-b]pyridazine98%;3-Bromo-6-chloroimidazo[1,2-β]pyridazine;6-Chloro-3-broMoiMidazo[1,2-a]pyridazine;3-Bromo-6-chloroimidazo[1,2-b]pyridazine ISO 9001:2015 REACH;-Bromo-6-chloroimidazo[1,2-b]pyridazine
CAS:13526-66-4
MF:C6H3BrClN3
MW:232.47
EINECS:
Product Categories:blocks;Bromides;Heterocycles;Imidazoles
Mol File:13526-66-4.mol
3-Bromo-6-chloroimidazo[1,2-b]pyridazine Structure
3-Bromo-6-chloroimidazo[1,2-b]pyridazine Chemical Properties
Melting point 156 °C
density 2.03
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
form Solid
pka0.73±0.30(Predicted)
Safety Information
Safety Statements 24/25
HS Code 29339900
MSDS Information
3-Bromo-6-chloroimidazo[1,2-b]pyridazine Usage And Synthesis
Uses3-Bromo-6-chloroimidazo[1,2-b]pyridazine is a reagent in the synthesis of imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
3-Bromo-6-chloroimidazo[1,2-b]pyridazine Preparation Products And Raw materials
Raw materials6-Chloroimidazo[2,1-f]pyridazine
Preparation ProductsIMIDAZO[1,2-B]PYRIDAZINE, 6-CHLORO-3-[3-(TRIFLUOROMETHOXY)PHENYL]-
Sulfamethoxypyridazine 3,8-DIBROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE Hydralazine 2-tert-Butyl-4,5-dichloro-3-2H-pyridazinone 3-Bromo-6-chloro-2-(4-chlorophenyl)imidazo[1,2-b]pyridazine 3-Bromo-6-chloroimidazo[1,2-b]pyridazine Pyridaphenthion 8-BROMO-6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE 3-Bromo-6-chloroimidazo[1,2-b]pyridazine 97% Hydrochlorothiazide Sulfachloropyridazine sodium SULFACHLOROPYRIDAZINE Thioridazine Bromine 4-BROMO-2-CHLOROIMIDAZO[1,5-B]PYRIDAZINE bromo-Dragonfly 3-BROMO-6-CHLORO-2-PHENYL-IMIDAZO[1,2-B]PYRIDAZINE ethyl 8-bromo-6-chloroimidazo[1,2-b]pyridazine-3-carboxylate

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.